Data Analytics Services for Multi-Site Infusion and Specialty Pharmacy Businesses
Revenue leakage in infusion organizations is rarely one problem. It’s six issues, compounding quietly across sites, payers, and workflows until the cumulative impact is too large to ignore. SolisRx connects your data across all of them.
4.8/5
610+ Reviews
One Data Layer. Six Areas of Visibility.
SolisRx doesn’t sell modules or software licenses. Every engagement starts with a specific business question: where is revenue leaking, why is a site underperforming, what will a buyer find in diligence. We then builds the analytics infrastructure to answer it reliably and on an ongoing basis.
The six service areas below reflect the natural structure of an infusion organization’s financial and operational performance.
The six service areas below reflect the natural structure of an infusion organization’s financial and operational performance.
Revenue Cycle Analytics
Find where revenue is leaking and build the monitoring to stop it.
The revenue cycle is where most infusion financial performance is made or lost. Patterns related to denial concentrations, authorization gaps, AR aging, underpayments, and payer-specific billing errors are hiding in claims data that hasn't been connected into a cross-site, cross-payer view.
SolisRx identifies the root causes, quantifies the dollar impact, and builds the exception monitoring that keeps those problems from recurring.
SolisRx identifies the root causes, quantifies the dollar impact, and builds the exception monitoring that keeps those problems from recurring.
Best Fit
Organizations with denial rates above 5%, unexplained AR aging, revenue or margin that’s not tracking with volume growth.
View Details
Referral & Growth Intelligence
Understand what’s driving referral volume, what’s at risk, and where growth is possible.
Referral performance is the leading indicator of an infusion organization’s financial future. The volume and quality of referrals changes before revenue does; by the time a revenue shortfall is visible, the referral pattern that caused it may be three to four months old.
SolisRx builds physician-level referral attribution, conversion tracking, visibility of key metrics like gross profit per encounter, and early-warning analytics that give commercial teams and leadership the visibility to act before the trend becomes a problem.
SolisRx builds physician-level referral attribution, conversion tracking, visibility of key metrics like gross profit per encounter, and early-warning analytics that give commercial teams and leadership the visibility to act before the trend becomes a problem.
Best Fit
Organizations experiencing referral softness at one or more sites, scaling a commercial team, or entering a new geography.
View Details
Intake Optimization
Reduce the time between referral and first treatment.
A referral that stalls before therapy start is revenue at risk, whether it’s because of Benefit Investigation, Prior Authorization, or a patient financial estimate. For high-margin therapies like IVIG or specialty biologics, a two-week intake delay is a measurable financial event. Across a full active referral caseload, those delays aggregate quickly.
SolisRx maps the referral-to-treatment pipeline, surfaces bottlenecks at each stage, and builds the monitoring and automation that prevents expiration gaps from turning into denials.
SolisRx maps the referral-to-treatment pipeline, surfaces bottlenecks at each stage, and builds the monitoring and automation that prevents expiration gaps from turning into denials.
Best Fit
Organizations with long referral-to-start times, high prior authorization denial rates, or limited visibility into where referrals stall after intake.
View Details
Market Expansion
Identify where your next site or service line should go, with data.
Most infusion expansion decisions are made with incomplete market intelligence: weak referral signals, conversations at conferences, demographic guesses, or commercial team intuition.
SolisRx replaces those inputs with claims-derived demand modeling, census and patient demographic data, referring physician network analysis, competitive landscape mapping, and site scoring that quantifies opportunity before capital is committed.
SolisRx replaces those inputs with claims-derived demand modeling, census and patient demographic data, referring physician network analysis, competitive landscape mapping, and site scoring that quantifies opportunity before capital is committed.
Best Fit
PE-backed platforms evaluating new geographies, operators considering new therapy programs, and organizations assessing whether to build versus acquire in a target market.
View Details
M&A Readiness
Prepare your business for PE diligence before the buyers arrive.
The analytics infrastructure that supports a clean quality-of-earnings review doesn’t get built in two weeks when a letter of intent arrives.
SolisRx builds it ahead of the process: normalized revenue data by payer, therapy, and site; denial trend documentation; referral attribution; and site-level profitability reporting. What the buyer finds in diligence matches what leadership already knows. That alignment is what makes transactions close.
SolisRx builds it ahead of the process: normalized revenue data by payer, therapy, and site; denial trend documentation; referral attribution; and site-level profitability reporting. What the buyer finds in diligence matches what leadership already knows. That alignment is what makes transactions close.
Best Fit
Infusion businesses within 12-24 months of a planned transaction, platform operators evaluating add-on acquisitions, and founders preparing for a first institutional process.
View Details
Executive Analytics
Give leadership a single, reliable view across every site.
Past four or five locations, running a multi-site infusion organization from site-level EHR reports and manually compiled spreadsheets becomes really hard. The questions leadership needs to answer require a cross-site analytics layer that no single source system provides. For example, which sites are generating the highest contribution margin, where payer concentration risk is building, which therapy categories are shifting.
SolisRx builds the executive dashboard infrastructure, KPI framework, and exception alert system that makes those answers available on demand.
SolisRx builds the executive dashboard infrastructure, KPI framework, and exception alert system that makes those answers available on demand.
Best Fit
Multi-site operators managing 4+ locations, PE-backed organizations with board reporting requirements, and leadership teams making strategic decisions with a data lag.
View Details
